Red Blood Cell Distribution Width and Neutrophil-to-Lymphocyte Ratio as Markers of Cardiovascular Disease and Vascular Calcification in Chronic Kidney Disease: A Large Cohort Study
Metabolites · 20.04.2026 · 16 (4) · 280
DOI: 10.3390/metabo16040280 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Metabolites, online erschienen am 20.04.2026. Verfasst von Anastasios Zagaliotis und 13 weiteren Autor:innen. Beteiligte Einrichtung: Second Department of Nephrology, School of Medicine, AHEPA Hospital, Aristotle University of Thessaloniki, 1 St. Kyriakidi Street, 54636 Thessaloniki…. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This work was funded by Deutsche Forschungsgemeinschaft granted to WJ-D., Deutsche Forschungsgemeinschaft project.
Abstract (Originalsprache)
Background/Objectives: Cardiovascular disease (CVD) in chronic kidney disease (CKD) arises from a multifaceted interplay of pathophysiological processes, including chronic inflammation, oxidative stress (OS), and accelerated vascular calcification (VC). Red blood cell distribution width (RDW) and the neutrophil-to-lymphocyte ratio (NLR) have emerged as simple, inexpensive, and readily available hematological indices that may capture these underlying disturbances. As such, they hold promise as accessible biomarkers for stratifying cardiovascular risk in patients with CKD.
Methods
This cross-sectional study enrolled 497 patients, comprising 477 with CKD across all stages and 20 controls. We evaluated the associations of RDW and NLR with both traditional and non-traditional cardiovascular risk factors, as well as with serum calcification propensity (T50). Spearman’s correlation and multivariable regression analysis were used to assess these relationships.
Results
Both RDW and NLR were significantly elevated in patients with established CVD (p < 0.001 for both) and demonstrated a progressive increase across advancing CKD stages (p < 0.001). RDW and NLR showed positive correlations with age, CVD duration, urea, phosphorus, parathormone, CRP, FG23, and mean carotid intima–media thickness (cIMT), while exhibiting inverse correlations with eGFR, serum albumin, hemoglobin, lipids, antioxidants such as superoxide dismutase, fetuin-A, and T50. Additionally, NLR correlated positively with the duration of hypertension and diabetes, as well as with albuminuria. Quartile analysis revealed a stepwise decline in T50 across increasing categories of RDW and NLR, supporting the link with impaired calcification defense. In multivariable analysis, T50 independently predicted NLR (β = −0.013; p = 0.018), whereas total cholesterol (β = −0.011; p = 0.019) and cIMT (β = 0.38; p = 0.018) emerged as independent determinants of RDW.
Conclusions
RDW and NLR strongly reflect the burden of inflammation, metabolic disturbance, and vascular dysfunction in patients across the CKD spectrum. The consistent associations with impaired calcification defense and with established cardiovascular risk markers underscore the potential value as accessible indicators of cardiovascular vulnerability in CKD. These findings support incorporating RDW and NLR into routine risk assessment and highlight T50 as a mechanistically relevant determinant of hematologic inflammation profiles.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Second Department of Nephrology, School of Medicine, AHEPA Hospital, Aristotle University of Thessaloniki, 1 St. Kyriakidi Street, 54636 Thessaloniki, Greece.
- Institute of Biochemistry, Faculty of Medicine, University of Nis, 18108 Nis, Serbia.
- Serbian Academy of Sciences and Arts, 11000 Beograd, Serbia.
- Faculty of Medicine, University of Nis, 18000 Nis, Serbia.
- Department of Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht University, 6211 LK Maastricht, The Netherlands.
- Helmholtz Institute for Biomedical Engineering, Biointerface Lab, RWTH Aachen University Hospital, 52074 Aachen, Germany.
ORCID-Profile: Stefanos Roumeliotis, Vasiliki Sgouropoulou, Rudolf Bittner, Willi Jahnen-Dechent, Leon J Schurgers, Vassilios Liakopoulos
Förderung
- This work was funded by Deutsche Forschungsgemeinschaft granted to WJ-D.
- Deutsche Forschungsgemeinschaft project
Zitieren
APA
Zagaliotis, A., Roumeliotis, A., Roumeliotis, S., Neofytou, I. E., Varouktsi, G., Leptokaridou-Mourtzila, E., Stamou, A., Sgouropoulou, V., Kocic, G., Veljkovic, A., Bittner, R., Jahnen-Dechent, W., Schurgers, L. J., & Liakopoulos, V. (2026). Red Blood Cell Distribution Width and Neutrophil-to-Lymphocyte Ratio as Markers of Cardiovascular Disease and Vascular Calcification in Chronic Kidney Disease: A Large Cohort Study. Metabolites, 16(4), 280. https://doi.org/10.3390/metabo16040280
Vancouver
Zagaliotis A, Roumeliotis A, Roumeliotis S, Neofytou IE, Varouktsi G, Leptokaridou-Mourtzila E, et al. Red Blood Cell Distribution Width and Neutrophil-to-Lymphocyte Ratio as Markers of Cardiovascular Disease and Vascular Calcification in Chronic Kidney Disease: A Large Cohort Study. Metabolites. 2026;16(4):280. doi:10.3390/metabo16040280
BibTeX
@article{Zagaliotis2026,
author = {Zagaliotis, Anastasios and Roumeliotis, Athanasios and Roumeliotis, Stefanos and Neofytou, Ioannis E and Varouktsi, Garyfallia and Leptokaridou-Mourtzila, Eirini and Stamou, Aikaterini and Sgouropoulou, Vasiliki and Kocic, Gordana and Veljkovic, Andrej and Bittner, Rudolf and Jahnen-Dechent, Willi and Schurgers, Leon J and Liakopoulos, Vassilios},
title = {Red Blood Cell Distribution Width and Neutrophil-to-Lymphocyte Ratio as Markers of Cardiovascular Disease and Vascular Calcification in Chronic Kidney Disease: A Large Cohort Study},
journal = {Metabolites},
year = {2026},
volume = {16},
number = {4},
pages = {280},
doi = {10.3390/metabo16040280}
}
EUVIMED